What does this research mean for the field?

Question

Accepted Answer

EGFR mutations in non-small cell lung cancer impair dendritic cell maturation via adenosine production, an immunosuppressive mechanism that can be overcome by a pH-responsive nanocarrier targeting CD73 to enhance the efficacy of PD-1 blockade. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

Overcoming EGFR‐Mediated Dendritic Cell Dysfunction to Enhance Anti‐tumor Immunity in EGFR‐Mutant NSCLC by Precisely Targeting CD73 With pH‐responsive Nanocarriers

Discussion

Member takes

Overview

Key Points

Cite This Study